LYME DISEASE AS A PUBLIC HEALTH CHALLENGE: A REVIEW OF RECENT EVIDENCE
Open Access
- 30 March 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (1(49))
Abstract
Lyme disease, primarily caused by the spirochete Borrelia burgdorferi transmitted by ticks of the genus Ixodes, is a growing public health problem in many regions of the world. The disease is characterized by a diverse clinical course, including early skin lesions such as erythema migrans, and late joint, neurological, cardiac, and, less frequently, chronic complications. The pathogenesis of Lyme disease is associated with the invasion of tissues by the spirochetes and their ability to evade the host immune response, leading to chronic inflammation. Diagnosis relies on a combination of clinical assessment and serological testing, while considering the limitations of false positive and negative results. Standard treatment includes antibiotic therapy tailored to the stage of disease. Prevention plays a key role and includes the use of repellents, appropriate clothing, environmental monitoring, and public education and awareness in endemic areas. Effective prevention and early diagnosis are essential to reduce morbidity and clinical complications.Keywords
This publication has 24 references indexed in Scilit:
- Prevention of Lyme Disease and Other Tick-Borne InfectionsInfectious Disease Clinics of North America, 2008
- Lyme Disease—European PerspectiveInfectious Disease Clinics of North America, 2008
- Lyme Disease in ChildrenInfectious Disease Clinics of North America, 2008
- Chronic Lyme Disease: A ReviewInfectious Disease Clinics of North America, 2008
- Borrelia burgdorferi–Traveling incognito?Microbes and Infection, 2006
- Artificial‐infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme diseaseEuropean Journal of Immunology, 2003
- Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosisBritish Journal of Dermatology, 2000
- Comparison of Azithromycin and Doxycycline in the Treatment of Erythema migransInfection, 2000
- Acrodermatitis chronica atrophicans: A chronic T-cell-mediated immune reaction against Borrelia burgdorferi?Journal of the American Academy of Dermatology, 1993
- Lyme DiseaseNew England Journal of Medicine, 1989